Lead sponsor
Hospital San Carlos, Madrid
1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of November 5, 2026.
1
Trials led
1
Ongoing
116
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Not applicable
1
Trials by status
By invitation
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Changes in Body Composition Following Pharmacological Treatment for Obesity.BMI ≥30not applicableBy invitation116